Masimo Co. (NASDAQ:MASI) EVP Sells $345,928.90 in Stock

Masimo Co. (NASDAQ:MASI) EVP Yongsam Lee sold 2,371 shares of Masimo stock in a transaction that occurred on Monday, June 24th. The shares were sold at an average price of $145.90, for a total value of $345,928.90. Following the sale, the executive vice president now directly owns 74,301 shares in the company, valued at approximately $10,840,515.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Yongsam Lee also recently made the following trade(s):

  • On Friday, July 12th, Yongsam Lee sold 5,989 shares of Masimo stock. The shares were sold at an average price of $151.83, for a total value of $909,309.87.
  • On Monday, July 15th, Yongsam Lee sold 12,500 shares of Masimo stock. The shares were sold at an average price of $151.82, for a total value of $1,897,750.00.
  • On Thursday, June 27th, Yongsam Lee sold 258 shares of Masimo stock. The shares were sold at an average price of $145.00, for a total value of $37,410.00.
  • On Tuesday, June 18th, Yongsam Lee sold 2,728 shares of Masimo stock. The stock was sold at an average price of $145.98, for a total value of $398,233.44.
  • On Thursday, June 20th, Yongsam Lee sold 9,035 shares of Masimo stock. The stock was sold at an average price of $146.60, for a total transaction of $1,324,531.00.

Shares of Masimo stock traded up $1.40 on Thursday, reaching $154.18. The stock had a trading volume of 162,288 shares, compared to its average volume of 431,307. Masimo Co. has a 1 year low of $96.14 and a 1 year high of $155.13. The stock has a market capitalization of $8.15 billion, a P/E ratio of 50.88, a P/E/G ratio of 3.04 and a beta of 1.14. The stock’s 50 day moving average price is $144.26.

Masimo (NASDAQ:MASI) last issued its quarterly earnings results on Monday, May 6th. The medical equipment provider reported $0.79 EPS for the quarter, beating analysts’ consensus estimates of $0.75 by $0.04. The business had revenue of $231.70 million for the quarter, compared to analysts’ expectations of $223.67 million. Masimo had a net margin of 22.49% and a return on equity of 18.61%. The business’s quarterly revenue was up 8.8% on a year-over-year basis. During the same period last year, the business earned $0.75 earnings per share. Equities analysts anticipate that Masimo Co. will post 3.12 earnings per share for the current fiscal year.

Institutional investors and hedge funds have recently bought and sold shares of the company. Claybrook Capital LLC purchased a new position in shares of Masimo in the 4th quarter worth about $25,000. West Oak Capital LLC bought a new stake in Masimo in the 1st quarter worth about $28,000. FinTrust Capital Advisors LLC bought a new stake in Masimo in the 1st quarter worth about $61,000. Valeo Financial Advisors LLC bought a new stake in Masimo in the 1st quarter worth about $69,000. Finally, NEXT Financial Group Inc increased its holdings in Masimo by 172.0% in the 2nd quarter. NEXT Financial Group Inc now owns 544 shares of the medical equipment provider’s stock worth $81,000 after buying an additional 344 shares in the last quarter. 83.02% of the stock is owned by hedge funds and other institutional investors.

Several research firms have recently issued reports on MASI. Needham & Company LLC restated a “hold” rating on shares of KLA-Tencor in a report on Tuesday, May 7th. BidaskClub upgraded shares of Winmark from a “sell” rating to a “hold” rating in a research note on Tuesday, May 14th. UBS Group restated a “buy” rating and set a $25.00 price target on shares of Infineon Technologies in a research note on Tuesday, May 7th. Stifel Nicolaus upped their target price on shares of Masimo from $150.00 to $160.00 and gave the stock a “buy” rating in a research note on Friday, May 17th. Finally, Zacks Investment Research lowered shares of Haynes International from a “hold” rating to a “sell” rating in a research note on Wednesday, May 8th. One research analyst has rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $154.25.

About Masimo

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.

See Also: What does earnings per share mean?

Insider Buying and Selling by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.